Skip to main content

MAPSE - Measure of Systolic Function



🚨Mitral Annular Plane Systolic Excursion (MAPSE)🚨


πŸ”΄Longitudinal displacement of the mitral valve annulus occurs during systole. This distance of this displacement relative to the apex of the heart can be tracked, measured and used as a marker for LV systolic function.


πŸ”΄Either the septal or lateral annulus of the mitral valve can be used for MAPSE. An average of the 2 measurements can be used. The M-Mode cursor is placed over the respective mitral valve annulus. 


πŸ”΄MAPSE is measured as the distance from the nadir of the M-Mode tracing to the peak 


πŸͺ§2D apical 4 chamber images are shown in diastole and systole. Longitudinal movement of the annulus during systole is observed. The M-Mode cursor is placed across the lateral annulus of the mitral valve and a tracing of the displacement during systole is obtained and measured.


MAPSE on Echocardiography: A Simple, Powerful Marker of LV Longitudinal Function


Mitral Annular Plane Systolic Excursion (MAPSE) is one of the most under-used yet remarkably useful echocardiographic parameters. It reflects longitudinal shortening of the left ventricle, a motion primarily generated by subendocardial longitudinal fibers—those most vulnerable to ischemia, hypertension, and myocardial disease.


What is MAPSE?


MAPSE measures how far the mitral annulus moves toward the LV apex during systole.

It is obtained in the apical 4-chamber view using M-mode aligned over the septal and lateral mitral annulus.


Because longitudinal fibers are affected early in many diseases, MAPSE often falls before EF drops, making it a sensitive marker of early LV dysfunction.



---


How to Measure MAPSE


1. Get a clear A4C view.



2. Place M-mode cursor exactly through the mitral annulus (septal and then lateral).



3. Measure the total systolic displacement from the annular peak in diastole to its peak in systole.



4. Average septal + lateral = Global MAPSE.





---


Normal Values


Region Normal Mild ↓ Moderate ↓ Severe ↓


Septal MAPSE >7 mm 6–7 mm 4–6 mm <4 mm

Lateral MAPSE >10 mm 8–10 mm 6–8 mm <6 mm

Average (Global) ≥10 mm 8–10 mm 6–8 mm <6 mm



Age reduces MAPSE slightly due to declining longitudinal mechanics.



---


Clinical Uses of MAPSE


1. Early Detection of LV Dysfunction


MAPSE decreases before EF declines, especially in:


Hypertension


Diabetes


CAD/ischemia


Amyloidosis


Chemotherapy-related cardiotoxicity


HFpEF



2. Quick Bedside Assessment in Critical Care


MAPSE is fast, reproducible, and less load-dependent than EF.

Useful in:


Shock (sepsis, cardiogenic shock)


ICU patients


Limited acoustic windows



3. Assessment of Longitudinal Function in HFpEF


HFpEF patients often have normal EF but reduced longitudinal strain and reduced MAPSE.


4. Prognostic Marker


Low MAPSE correlates with increased mortality in:


Acute coronary syndrome


Heart failure


Post–cardiac surgery patients




---


How to Interpret MAPSE


High MAPSE


Hyperdynamic LV (sepsis, anemia, fever)


Early compensated states



Low MAPSE


LV systolic dysfunction (global or regional)


Subendocardial ischemia


Infiltrative cardiomyopathies (amyloidosis → especially low “septal MAPSE”)


RV pressure overload (can reduce septal MAPSE due to septal tethering)


Aging




---


MAPSE vs GLS vs EF


Parameter Strengths Limitations


MAPSE Fast, simple, reproducible; good for low-quality images; reflects longitudinal function Angle-dependent; only longitudinal mechanics

GLS Most sensitive marker of LV systolic dysfunction Requires good image quality + speckle tracking

EF Common and widely understood Load-dependent, may appear normal in early disease



MAPSE is excellent for quick assessment and early detection, while GLS offers richer detail and EF provides traditional global function.



---


When MAPSE Is Most Useful (Real-World)


When images are poor


When strain software is unavailable


Rapid assessment in ER/ICU


Tracking subtle change in cardiotoxicity patients


Evaluating LV function in HFpEF patients


Infiltrative cardiomyopathy (septal MAPSE often strikingly low)




---


Bottom Line


MAPSE is a simple, powerful, and often overlooked marker of LV longitudinal systolic function. It adds significant value to routine echo, especially where GLS or high-quality images are not available. A quick MAPSE measurement can detect dysfunction earlier than EF, improve risk stratification, and guide management in both acute and chronic cardiac conditions.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.